Ethoxycarbonyl Group

Ethoxycarbonyl Group

SCHEMBL28801419

CCOC=O.Cc1cnc2ccccc2n1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
CYP1A2 P05177 1/20 0.45
CYP2C9 P11712 1/20 0.45
HIF1A Q16665 1/20 0.45
NPC1 O15118 6/20 0.43
MAPT P10636 4/20 0.43
KMT2A Q03164 5/20 0.41
RAB9A P51151 5/20 0.41
MEN1 O00255 4/20 0.41
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
PDE10A Q9Y233 1/20 0.40
GAA P10253 1/20 0.39
HPGD P15428 3/20 0.39
HTT P42858 2/20 0.39
ATM Q13315 1/20 0.39
HTR3A P46098 1/20 0.39
HRH4 Q9H3N8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethoxycarbonyl Group SCHEMBL28040925 0.84 TDP1 (0.39) ALDH1A1KDM4ESMN1; SMN2CYP1A2NPC1
Ethoxycarbonyl Group SCHEMBL28040931 0.84 TDP1 (0.39) ALDH1A1KDM4ESMN1; SMN2CYP1A2NPC1
Ethoxycarbonyl Group SCHEMBL28038348 0.83 ALDH1A1 (0.43) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
Ethoxycarbonyl Group SCHEMBL28040581 0.82 ELANE (0.37) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
Ethoxycarbonyl Group SCHEMBL28040923 0.82 ELANE (0.37) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
Ether SCHEMBL16742369 0.82 ALDH1A1 (0.49) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
Ethoxycarbonyl Group SCHEMBL27894122 0.81 TSHR (0.39) ALDH1A1KDM4ESMN1; SMN2CYP1A2NPC1
Acetaldehyde SCHEMBL11425484 0.81 ALDH1A1 (0.44) ALDH1A1KDM4ESMN1; SMN2CYP1A2NPC1
Quinoxaline SCHEMBL27913231 0.80 ALDH1A1 (0.41) ALDH1A1KDM4ESMN1; SMN2CYP1A2CYP2C9
SCHEMBL28571 0.79 PDE10A (0.52) ALDH1A1KDM4ESMN1; SMN2CYP1A2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102770435-B Pyrazolopyrimidines and the purposes as PDE10 inhibitor thereof MITSUBISHI TANABE PHARMA CORP. (JP) 2015-11-25 CN disclosed
CN-105061338-A 3-methyl-quinoxaline-2-carboxylic acid chemical synthesis method based on ionic liquid system PINGYUAN WEIFENG YONGZHU TECHNOLOGY CO LTD 2015-11-18 CN disclosed
CN-102770435-A Pyrazolopyrimidine compounds and their use as PDE10 inhibitors MITSUBISHI TANABE PHARMA CORP 2012-11-07 CN disclosed